Approval · Notice of Compliance 30819 · 2023

KETALAR: Notice of Compliance 30819

Issued May 24, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 30819
Date: May 24, 2023
Company: Searchlight Pharma Inc.Montreal, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative: Change in Product Ownership

Products in this notice

Brand	DIN	Status today
KETALAR	00224391	Marketed
KETALAR	00224405	Marketed

Medicinal ingredients

KETAMINE HYDROCHLORIDE 10 MG per ML
KETAMINE HYDROCHLORIDE 50 MG per ML